BIOMAT Database Logo BIOMAT Database Logo

Carnitine metabolism in patients with chronic renal failure: effect of L-carnitine supplementation. 1987

C Wanner, and S Förstner-Wanner, and C Rössle, and P Fürst, and P Schollmeyer, and W H Hörl
Department of Medicine, University of Freiburg, Federal Republic of Germany.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010530 Peritoneal Dialysis Dialysis fluid being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure. Dialyses, Peritoneal,Dialysis, Peritoneal,Peritoneal Dialyses
D010531 Peritoneal Dialysis, Continuous Ambulatory Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. CAPD,Continuous Ambulatory Peritoneal Dialysis
D002331 Carnitine A constituent of STRIATED MUSCLE and LIVER. It is an amino acid derivative and an essential cofactor for fatty acid metabolism. Bicarnesine,L-Carnitine,Levocarnitine,Vitamin BT,L Carnitine
D004951 Esterification The process of converting an acid into an alkyl or aryl derivative. Most frequently the process consists of the reaction of an acid with an alcohol in the presence of a trace of mineral acid as catalyst or the reaction of an acyl chloride with an alcohol. Esterification can also be accomplished by enzymatic processes. Esterifications
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

C Wanner, and S Förstner-Wanner, and C Rössle, and P Fürst, and P Schollmeyer, and W H Hörl
Carnitine metabolism in chronic renal failure.
October 1987, Kidney international. Supplement,
C Wanner, and S Förstner-Wanner, and C Rössle, and P Fürst, and P Schollmeyer, and W H Hörl
[Effect of L-carnitine supplementation on lipid metabolism of renal failure, dialysis-dependent children and adolescents].
October 1991, Infusionstherapie (Basel, Switzerland),
C Wanner, and S Förstner-Wanner, and C Rössle, and P Fürst, and P Schollmeyer, and W H Hörl
The effect of L-carnitine on insulin resistance in hemodialysed patients with chronic renal failure.
January 1999, Journal of nephrology,
C Wanner, and S Förstner-Wanner, and C Rössle, and P Fürst, and P Schollmeyer, and W H Hörl
Carnitine metabolism in valproate-treated rats: the effect of L-carnitine supplementation.
November 1987, Pediatric research,
C Wanner, and S Förstner-Wanner, and C Rössle, and P Fürst, and P Schollmeyer, and W H Hörl
The effect of propionyl L-carnitine on skeletal muscle metabolism in renal failure.
June 1997, Clinical nephrology,
C Wanner, and S Förstner-Wanner, and C Rössle, and P Fürst, and P Schollmeyer, and W H Hörl
Dyslipidemia, oxidative stress and cardiac dysfunction in children with chronic renal failure: effects of L-carnitine supplementation.
January 2003, Annals of Saudi medicine,
C Wanner, and S Förstner-Wanner, and C Rössle, and P Fürst, and P Schollmeyer, and W H Hörl
Effect of L-carnitine supplementation in hemodialysis patients.
July 2001, Nephron,
C Wanner, and S Förstner-Wanner, and C Rössle, and P Fürst, and P Schollmeyer, and W H Hörl
[Study of aerobic capacity in chronic hemodialized patients: effect of L-carnitine supplementation].
April 2008, Medicina clinica,
C Wanner, and S Förstner-Wanner, and C Rössle, and P Fürst, and P Schollmeyer, and W H Hörl
Effect of L-carnitine supplementation on secondary hyperparathyroidism and bone metabolism in hemodialyzed patients.
August 2007, Calcified tissue international,
C Wanner, and S Förstner-Wanner, and C Rössle, and P Fürst, and P Schollmeyer, and W H Hörl
[Levels of L-carnitine in serum of patients with chronic renal failure treated by hemodialysis (HD)].
April 1998, Polskie Archiwum Medycyny Wewnetrznej,
Copied contents to your clipboard!